We came across a bullish thesis on AbbVie Inc. (ABBV) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on ABBV. AbbVie Inc. (ABBV)'s share was trading at $171.56 as of Jan 17th. ABBV’s trailing and forward P/E were 59.78 and 14.31 respectively according to Yahoo Finance.
[caption id="attachment_1238886" align="aligncenter" width="768"]AbbVie (ABBV) recently experienced a significant setback with the failure of its schizophrenia drug...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.